Active — Not RecruitingNot Applicable

MoVE Trial: Motivational Strategies to Empower African Americans to Improve Dialysis Adherence

United States176 participantsStarted 2023-10-09

Plain-language summary

MoVE Trial is a randomized clinical trial designed to rigorously test the impact of a behavioral intervention (culturally tailored motivational interviewing - (MOVE)) delivered by trained health coaches, on hemodialysis treatment non-adherence. It is a a two-arm, parallel group randomized clinical trial with 24-week follow-up. It involves completion of surveys by patients enrolled in the study. It also involves participation in motivational interviewing sessions by patients who are randomized to the intervention (MI).

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * African American * Receiving hemodialysis treatments * Been on hemodialysis for more than 30 days * 18 years of age and older * Within a 2-month look back at the time of screening, patients who have missed at least one dialysis session or shortened at least one dialysis session by 15 minutes. Exclusion Criteria: * Not self-identified as African American * Impaired with mental status or severe illness * Non-English speaking * No documented evidence of dialysis treatment non-adherence * Missed or shortened treatments due to hospitalizations or excused travel * Terminal condition * Living in a nursing home/rehab * Planned transplant within the next 6 months * Planned conversion to peritoneal dialysis within the next 6 months

What they're measuring

Dialysis Treatment Adherence - Shortened Session

Timeframe: Baseline to Week 12

Change in Perceived Competence

Timeframe: Week 8

Trial details

NCT IDNCT05735743

SponsorVanderbilt University Medical Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2027-11-01